|
Should one derive risk difference from the odds ratio?
|
|
622
|
79798
|
March 17, 2026
|
|
Estimand when treatment delays disease onset
|
|
4
|
144
|
March 5, 2026
|
|
FDA Draft Guidance: Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products
|
|
10
|
936
|
March 2, 2026
|
|
Narratively generative modeling
|
|
1
|
115
|
February 24, 2026
|
|
ABCLOC: bootstrap method for overfitting-corrected model performance metrics
|
|
3
|
102
|
February 7, 2026
|
|
Analysis of treatment switching using observational data
|
|
2
|
116
|
January 31, 2026
|
|
Judeo-Christian insurance claims database analysis
|
|
11
|
551
|
January 27, 2026
|
|
Optimism Correction after LASSO in clinical prediction models
|
|
18
|
513
|
January 22, 2026
|
|
CPM performance metrics: Adjustment for repeated measures
|
|
2
|
101
|
January 18, 2026
|
|
Uncertainty in c-index (AUROC) with clustered data
|
|
10
|
1368
|
January 17, 2026
|
|
Combining splines with LASSO in clinical prediction models
|
|
9
|
200
|
January 13, 2026
|
|
Bootstrapped variable selection in the presence of competing risk
|
|
7
|
145
|
January 12, 2026
|
|
RMS Missing Data
|
|
42
|
28346
|
January 10, 2026
|
|
Nature Sleep Prediction Study
|
|
2
|
102
|
January 7, 2026
|
|
Prediction Recruitment Duration
|
|
2
|
92
|
January 6, 2026
|
|
Statistically Efficient Ways to Quantify Added Predictive Value of New Measurements
|
|
86
|
23748
|
December 19, 2025
|
|
Should causal modeling be a required part of a NIH grant applications?
|
|
1
|
122
|
December 17, 2025
|
|
Model Performance with Repeat Predictions
|
|
11
|
1483
|
December 15, 2025
|
|
Cause-Agnostic RCT (CAR)
|
|
9
|
488
|
December 12, 2025
|
|
A High-Fiber Plant-Based Diet in Myeloma Precursor Disorders – Results from the 2 NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model
|
|
2
|
106
|
December 11, 2025
|
|
MICE Imputation Models
|
|
10
|
457
|
December 6, 2025
|
|
Optimising models for calibration
|
|
51
|
1111
|
December 5, 2025
|
|
Omission of *absolute* risk reduction from NEJM Editorial on PSA testing
|
|
14
|
485
|
November 27, 2025
|
|
Individual response
|
|
266
|
49265
|
November 17, 2025
|
|
Feedback on BayeScores: A Bayesian AFT Mixture Cure Model for Quantifying Clinical Benefit
|
|
3
|
169
|
November 11, 2025
|
|
Examples of solid causal inferences from purely observational data
|
|
27
|
13154
|
November 9, 2025
|
|
Random effects analysis in clinical trials
|
|
2
|
152
|
November 4, 2025
|
|
Critiquing risk factor analysis
|
|
25
|
1208
|
October 29, 2025
|
|
RMS Multivariable Modeling Strategies
|
|
76
|
32405
|
October 28, 2025
|
|
Time‐varying covariate vs. “matching on time” to handle second event
|
|
14
|
264
|
October 27, 2025
|